Thursday, 04 June 2026

 

 

LATEST NEWS Centre Approves ₹4,416-Crore Highway Project to Boost MP Growth, Jobs French Open : Flavio Cobolli ends Auger-Aliassime's hopes, reaches first major semifinal BJP-RSS harbour anti-Adivasi mindset says Rahul Gandhi Keshav Prasad Maurya meets Narendra Modi CM chair belongs to people : D.K. Shivakumar after first cabinet meeting Shubman Gill's India hit ground running in New Chandigarh ahead of Afghanistan Test 1 pc shift to ethanol-powered vehicles can save India nearly Rs 195 crore in forex says Hardeep Singh Puri French Open : Diana Shnaider scripts epic comeback to stun No.1 seed Aryna Sabalenka Nitish Kumar visits JD-U office Govt holds industry interaction on PM-SETU scheme for Rajasthan cluster to boost skilling Himanta Biswa Sarma briefs Droupadi Murmu on state’s growth Nitin Gadkari Addresses the Launch of Hero MotoCorp’s First Flex-Fuel Motorcycles in New Delhi Suvendu Adhikari chairs third cabinet meeting, key decisions announced Dr Nomalungelo Gina holds bilateral meeting with Dr Jitendra Singh 42 Panchayats Honoured for Driving Rural Transformation at National Panchayat Awards 2025 Ceremony in New Delhi Two-day workshop on “Advanced Technological Intervention in Smart Farming” C. P. Radhakrishnan Releases Book When Audit Matters Edited by Former CAG Shri Vinod Rai Thongsavan Phomvihane Calls On Droupadi Murmu Gulab Chand Kataria Reviews Preparations and Infrastructure Upgradation Plans for Asian Relay Athletics Championship 2027 H. Rajesh Prasad Launches GGDSD College Prospectus for Academic Session 2026–27 “Nun Chai Talks”: A new kind of Public Conversation at Knowledge Centre Bandipora

 

'Mild' link between Pfizer, Moderna jabs & heart inflammation: WHO

Delta Plus Covid variant, Delta Covid-19 variant, Health, Study, Coronavirus, Research, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Remdesivir, Geneva, World Health Organisation, WHO

Web Admin

Web Admin

5 Dariya News

Geneva , 11 Jul 2021

Last updated on: Jul 11, 2021, 00:00 IST

The World Health Organisation (WHO) has found very rare cases of heart inflammation following vaccination with the mRNA Covid-19 vaccines such as Pfizer and Moderna, but the benefits still outweigh the risks.The cases were mild, and found more often in young men after the second dose, said the global health body.WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that cases of myocarditis and pericarditis had been reported in the US and several other countries. Myocarditis is an inflammation of the heart muscle, while pericarditis is an inflammation of the lining that surrounds the heart."Very rare cases of myocarditis and pericarditis have been observed following vaccination with the mRNA Covid-19 vaccines. These cases occurred more often in younger men and after the second dose of the vaccine, typically within a few days after vaccination. Current evidence suggests a likely causal association between myocarditis and the mRNA vaccines," the WHO said in a statement.The available data also suggest that the immediate cause of myocarditis and pericarditis following vaccination is generally mild and responds to rest, treatment with nonsteroidal anti-inflammatory drugs, etc.Nearly 40.6 cases of myocarditis per million second doses among males and 4.2 cases per million among females have been reported as of June 11, 2021 in people aged between 12 and 29 years who received the mRNA Covid-19 vaccines, according to the data in the US Vaccine Adverse Events Reporting System (VAERS).For persons over 30 years of age, the reporting rates were 2.4 and 1.0 per million second doses, respectively, for males and females.The link was also confirmed by the European Medicines Agency, Europe's drug regulator.EMA's Pharmacovigilance Risk Assessment Committee (PRAC) confirmed "a plausible causal relationship between myocarditis and the mRNA vaccines" in Europe.Yet, "the benefits of mRNA Covid-19 vaccines continue to outweigh the risks of myocarditis and pericarditis even among young people, the WHO said.Symptoms indicative of myocarditis or pericarditis include new onset and persisting chest pain, shortness of breath, or palpitations following vaccination.The global health body advised clinicians to be aware of the risk of myocarditis and pericarditis with mRNA vaccines and people most likely to be affected -- adolescent or young males. It also asked vaccinated individuals to seek immediate medical attention if they develop any such conditions.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Health , Study , Coronavirus , Research , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Remdesivir , Geneva , World Health Organisation , WHO

 

 

related news

 

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2026 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD